Filing Details
- Accession Number:
- 0000899243-18-019566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-06 21:41:52
- Reporting Period:
- 2018-07-05
- Accepted Time:
- 2018-07-06 21:41:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1701108 | Spero Therapeutics Inc. | SPRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1720974 | Ankit Mahadevia | C/O Spero Therapeutics, Inc. 675 Massachusetts Avenue, 14Th Floor Cambridge MA 02139 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-07-05 | 3,076 | $5.90 | 68,893 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-05 | 3,076 | $17.62 | 65,817 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-07-06 | 1,600 | $5.90 | 67,417 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-07-06 | 500 | $17.50 | 66,917 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-06 | 100 | $17.55 | 66,817 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-06 | 400 | $17.58 | 66,417 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-06 | 100 | $17.62 | 66,317 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-06 | 100 | $17.71 | 66,217 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-06 | 200 | $17.90 | 66,017 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-07-06 | 200 | $17.92 | 65,817 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-07-05 | 3,076 | $0.00 | 3,076 | $5.90 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-07-06 | 1,600 | $0.00 | 1,600 | $5.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 120,488 | 2027-07-05 | No | 4 | M | Direct | |
| 118,888 | 2027-07-05 | No | 4 | M | Direct |
Footnotes
- The option exercises and related sales (totaling 4,676 shares) reported in this Form 4 were made pursuant to a Rule 10b5-1 trading plan previously entered into by the Reporting Person in December 2017.
- Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.
- All shares underlying this option were fully vested as of July 6, 2017.
Billionaire Hedge Funds
